Skip to main content
Erschienen in: Reactions Weekly 1/2023

01.07.2023 | Case report

Cotrimoxazole/pembrolizumab

Toxic epidermal necrolysis and bullous lichenoid drug exanthema: 2 case reports

Erschienen in: Reactions Weekly | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Golle L, et al. [Bullous drug reaction after pembrolizumab administration: two case reports]. [German]. Dermatologie (Heidelberg, Germany) 73 : 959-964, No. 12, Dec 2022. Available from: URL: http://doi.org/10.1007/s00105-022-05018-0 [German; summarised from a tranlsation] Golle L, et al. [Bullous drug reaction after pembrolizumab administration: two case reports]. [German]. Dermatologie (Heidelberg, Germany) 73 : 959-964, No. 12, Dec 2022. Available from: URL: http://​doi.​org/​10.​1007/​s00105-022-05018-0 [German; summarised from a tranlsation]
Metadaten
Titel
Cotrimoxazole/pembrolizumab
Toxic epidermal necrolysis and bullous lichenoid drug exanthema: 2 case reports
Publikationsdatum
01.07.2023
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2023
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-023-42239-9

Weitere Artikel der Ausgabe 1/2023

Reactions Weekly 1/2023 Zur Ausgabe

Case report

Multiple drugs

Case report

Clozapine